Announcements Trials
Browse Landscape

Phase

Phase 2 22Phase NA 11Phase 3 9Phase 1/2 9Phase 4 5Phase EARLY_PHASE1 3Phase 1 3Phase 2/3 1

Status

Recruiting 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 37Gastrointestinal 35Genitourinary 23Lymphoid 22Breast 18Other solid neoplasm 14Dermatologic 12Sarcoma 10Plasma cell 10Other hematologic neoplasm 10Gynecologic 10Thoracic 9Head & Neck 9Tumor-Agnostic 5Endocrine 5Classical hematology 3Other 2Myeloid 2NET 1

Conditions

Venous Thrombosis 1Venous Thromboembolism 1Thrombosis 1Thromboembolism 1Thrombocytopenia 1Pulmonary Embolism 1Lymphoma, B-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Cytopenia 1Burkitt Lymphoma 1Anemia, Hemolytic, Autoimmune 1

Interventions

decitabine and cedazuridine drug combination 1apixaban 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Classical hematology × 90 days × Clear all
NCT07205315 2026-05-27

A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia

Grit Biotechnology

Phase EARLY_PHASE1 Recruiting
28 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Hemolytic, Autoimmune, Burkitt Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT06802146 2026-04-23

Early Intervention in High Risk CCUS

Dana-Farber Cancer Institute

Phase EARLY_PHASE1 Recruiting
108 enrolled
Classical hematology

Cytopenia

NCT06886516 2026-04-15

Apixaban in Thrombocytopenia

Beth Israel Deaconess Medical Center

Phase EARLY_PHASE1 Recruiting
30 enrolled
Classical hematology

Pulmonary Embolism, Thrombocytopenia, Thromboembolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡